Feldman Paul L Insider Trading -- Recent SEC Form 4 Transactions
Feldman Paul L (CIK 2050705) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-19). Recent activity: Buy AKTS (55,035 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-19 | Aktis Oncology, Inc. (AKTS) | Chief Scientific Officer | Buy | 55,035 | $104,688 |
Source: SEC Form 4 filings · as of 2026-11-19